German American Bancorp Inc. Takes $3.38 Million Position in Danaher Corporation $DHR

German American Bancorp Inc. bought a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, HoldingsChannel reports. The firm bought 17,722 shares of the conglomerate’s stock, valued at approximately $3,376,000.

Several other large investors also recently modified their holdings of DHR. State Street Corp lifted its holdings in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after buying an additional 472,608 shares during the period. Capital International Investors increased its stake in shares of Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after buying an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after buying an additional 1,334,221 shares during the period. Wellington Management Group LLP raised its holdings in shares of Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after acquiring an additional 1,517,904 shares in the last quarter. Finally, Norges Bank bought a new position in shares of Danaher during the fourth quarter valued at approximately $2,177,106,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Evercore restated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $245.00 target price on shares of Danaher in a research report on Tuesday, April 21st. Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, HSBC reduced their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Price Performance

Shares of DHR stock opened at $202.51 on Monday. The stock has a market cap of $142.37 billion, a price-to-earnings ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78. The business’s fifty day moving average is $193.14 and its 200 day moving average is $192.91. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.77 earnings per share. Research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.